In critically ill patients, AKI frequencies did not display significant differences across virus groups: COVID-19 (51%), ACE2-associated respiratory viruses (56%), and non-ACE2-associated viruses (63%), nor between ACE2-associated respiratory viruses and non-ACE2-associated viruses (p = 0.624). This evidence concerns the gene ACE2 and COVID-19.